全文获取类型
收费全文 | 1171075篇 |
免费 | 71993篇 |
国内免费 | 1441篇 |
专业分类
耳鼻咽喉 | 14847篇 |
儿科学 | 33116篇 |
妇产科学 | 27747篇 |
基础医学 | 159295篇 |
口腔科学 | 30560篇 |
临床医学 | 101218篇 |
内科学 | 225690篇 |
皮肤病学 | 20608篇 |
神经病学 | 94308篇 |
特种医学 | 47413篇 |
外国民族医学 | 80篇 |
外科学 | 189903篇 |
综合类 | 21298篇 |
现状与发展 | 1篇 |
一般理论 | 293篇 |
预防医学 | 86912篇 |
眼科学 | 24754篇 |
药学 | 85842篇 |
3篇 | |
中国医学 | 2838篇 |
肿瘤学 | 77783篇 |
出版年
2019年 | 6992篇 |
2018年 | 33054篇 |
2017年 | 26248篇 |
2016年 | 30160篇 |
2015年 | 10912篇 |
2014年 | 14309篇 |
2013年 | 20627篇 |
2012年 | 34400篇 |
2011年 | 50330篇 |
2010年 | 35844篇 |
2009年 | 28288篇 |
2008年 | 48938篇 |
2007年 | 53571篇 |
2006年 | 30131篇 |
2005年 | 31192篇 |
2004年 | 31710篇 |
2003年 | 32127篇 |
2002年 | 29285篇 |
2001年 | 55772篇 |
2000年 | 57849篇 |
1999年 | 47775篇 |
1998年 | 11549篇 |
1997年 | 10240篇 |
1996年 | 10121篇 |
1995年 | 9416篇 |
1994年 | 8772篇 |
1993年 | 8017篇 |
1992年 | 35984篇 |
1991年 | 34429篇 |
1990年 | 33286篇 |
1989年 | 32338篇 |
1988年 | 29395篇 |
1987年 | 28649篇 |
1986年 | 26690篇 |
1985年 | 25525篇 |
1984年 | 18173篇 |
1983年 | 15426篇 |
1982年 | 8084篇 |
1979年 | 16051篇 |
1978年 | 10810篇 |
1977年 | 9216篇 |
1976年 | 8083篇 |
1975年 | 8748篇 |
1974年 | 10635篇 |
1973年 | 9967篇 |
1972年 | 9475篇 |
1971年 | 8944篇 |
1970年 | 8543篇 |
1969年 | 8051篇 |
1968年 | 7308篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
2.
Karl Johnson Katherine W. Saylor Isabella Guynn Karen Hicklin Jonathan S. Berg Kristen Hassmiller Lich 《Genetics in medicine》2022,24(2):262-288
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing. 相似文献
3.
4.
Karen Kayser Ariel Washington Lesley M. Harris Barbara Head 《Journal of psychosocial oncology》2021,39(1):17-34
Abstract
Purpose
Financial hardship can be a major cause of distress among persons with cancer, resulting in chronic stress and impacting physical and emotional health. This paper provides an analysis of the lived experience of cancer patients’ financial hardship from diagnosis to post-treatment. 相似文献5.
6.
7.
8.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
9.
10.